结合癌位缺氧诱导因子2α与prolyl氧酶域2的结构基础
William D Figg1, Giorgia Fiorini1, Rasheduzzaman Chowdhury1
1Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford, Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
Proteins
|July 14, 2023
概括
低氧诱导因子基酶 (PHDs) 调节HIFα降解. 结构研究揭示了PHD2结合模式,为贫血,红细胞瘤和清细胞癌 (ccRCC) 提供了新的治疗方法.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 分子医学是分子医学.
背景情况:
- 低氧诱导因子 (HIF) 是细胞对氧气水平反应的关键调节者.
- 高基基酶 (PHDs) 向HIFα子单元进行降解,这对于氧气稳定至关重要的过程.
- HIF通路的失调与贫血,红细胞瘤,肺高血压和清细胞细胞癌 (ccRCC) 等疾病有关.
研究的目的:
- 阐明PHD2与HIFα-ODD域相互作用的结构基础.
- 了解临床相关突变对PHD-HIFα相互作用的影响.
- 探索针对PHD-HIF途径的新型治疗策略.
主要方法:
- 使用X射线结晶学来确定与HIF2α-ODD域复合的PHD2的结构.
- 联合结晶与辅助基质2-oxoglutarate和抑制剂N-oxalylglycine进行.
- 生物化学研究和对现有结构数据的分析被整合在一起.
主要成果:
- 在基质或抑制剂的存在下,晶体结构揭示了PHD2与HIF2α-ODD域的独特结合模式.
- 这些发现提供了关于HIFα和PHD2基因突变如何影响蛋白质相互作用的见解.
- 结构信息突出了PHD异型选择性和HIF2α封存的潜在机制.
结论:
- 确定的结构提供了对PHD2-HIFα相互作用的分子理解.
- 这些知识可以指导针对HIF相关疾病的向治疗的开发,包括贫血和ccRCC.
- 未来的治疗途径可能涉及PHD异型选择性抑制剂和HIF2α隔离策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


